Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid is a synthetic small molecule compound. It is structurally related to peptide-based inhibitors and contains a naphthalenesulfonamide group, an amidinophenylalanine residue, and a D-pipecolinic acid moiety. The compound has been studied primarily as an experimental tool in structural biology and biochemistry, particularly for its ability to bind to serine proteases such as trypsin-like enzymes. Its mechanism of action involves competitive inhibition at the active site of these proteases by mimicking substrate interactions, thereby blocking enzymatic activity. There are no known clinical indications or approved therapeutic uses for this molecule; it is not approved by regulatory agencies for any medical condition[10].
- Other names
- N-ALPHA-(2-NAPHTHYLSULFONYL)-N-(3-AMIDINO-L-PHENYLALANINYL)-D-PIPECOLINIC ACID
02
Targets
PRSS1 (Trypsin family)
Beyond the preview
Go deeper on N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid.